Home Cart Sign in  
Chemical Structure| 1197300-24-5 Chemical Structure| 1197300-24-5

Structure of TGR5 Receptor Agonist
CAS No.: 1197300-24-5

Chemical Structure| 1197300-24-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TGR5 receptor agonist, a potent TGR5 (GPCR19) agonist, showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5).

Synonyms: CCDC; TGR5; MDK00245

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TGR5 Receptor Agonist

CAS No. :1197300-24-5
Formula : C18H14Cl2N2O2
M.W : 361.22
SMILES Code : O=C(C1=C(C)ON=C1C2=CC=CC=C2Cl)N(C3=CC=C(Cl)C=C3)C
Synonyms :
CCDC; TGR5; MDK00245
MDL No. :MFCD17169972
InChI Key :IGRCWJPBLWGNPX-UHFFFAOYSA-N
Pubchem ID :44605616

Safety of TGR5 Receptor Agonist

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H320-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of TGR5 Receptor Agonist

GPCR

Isoform Comparison

Biological Activity

Description
TGR5 Receptor Agonist (CCDC), a robust agonist of Takeda G protein-coupled receptor 5 (TGR5; GPCR19), demonstrates enhanced effectiveness in U2-OS and melanophore cells with pEC50s of 6.8 and 7.5, respectively. This agonist triggers peripheral and central sensitivity to bladder distension in mice and elevates intracellular Ca2+ levels. It also reduces food consumption and heightens insulin sensitivity in diet-induced obese mice. The TGR5 Receptor Agonist is applicable in studies on diabetes, bladder hypersensitivity, and obesity control[1][2][3][4].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01674946 Echolocation Phase 1 Completed - Switzerland ... More >> University Hospital Basel, Phase 1 Research Unit Basel, Switzerland, 4031 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.77mL

0.55mL

0.28mL

13.84mL

2.77mL

1.38mL

27.68mL

5.54mL

2.77mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories